Presentation of the Centre

MSCI - founded in 1932 as the Radium Institute by double Nobel Prize laureate Maria Sklodowska-Curie in collaboration with the Polish Government - is a modern comprehensive cancer centre and a governmental research institute involved in basic/preclinical research, clinical trials, diagnostic and treatment, and education in oncology.

It involves several facilities located in Warszawa, Gliwice, and Krakow and provides care to patients from the whole country.

Since 2020, MSCI was awarded the role of the National Research Institute, being a leader of the National Cancer Strategy and the National Oncology Network. MSCI is also the National Coordinating Center for population screening and primary cancer prevention and runs the National Cancer Registry.

Main Research Activities

The main research activities are based on close collaboration with on-site basic science departments and cancer-orientated clinical wards. The repository of tissues and medical data of cancer patients offers unique research opportunities.

MSCI is experienced in:

• a multidisciplinary approach; applying highly specialised procedures (70% of patients receive the combined treatment), monitoring any complications and unwanted side effects of treatment.
• complex diagnostic facilities, including molecular biology, genetics and proteomics, and Center of Excellence for Precision Oncology
• direct clinical application of ongoing research.
• conducting clinical trials (non-commercial trials in cooperation with EORTC and the Polish Medical Research Agency, and commercial – in total about 500 clinical trials only in oncology).
• Cooperation with Patients Advocacy Groups

Core Facilities

The clinical part is located in a 10-floor building, where each floor is a separate cancer-specific department with a multidisciplinary team providing comprehensive care for cancer patients (surgery, radiotherapy, systemic treatment, psychotherapy and physiotherapy). In addition, there are Day Care Centers, Outpatient Clinics and the Cancer Prevention Centre (involved in many international projects, e.g. the Nordic-European Initiative on Colorectal Cancer, European Polyp Surveillance Trial and Era-NET Transcan), the Center for Research and Development, the Early-Phase Clinical Trials Unit, the Hyperthermia Department, The Centre for Excellence in Precision Oncology, and CART Facility (under development).

Presentation of the Institute

The Institute of Mother and Child (IMC) is an academic and research institution, with 60 years of tradition and a proven track record both in Poland and internationally. IMC employs highly qualified specialists with strong professional and scientific credentials, including national consultants in various fields of medicine. To meet the health needs of modern society, IMC collaborates with numerous scientific institutions and organizations both in Poland and abroad. Our Department of Oncology and Surgical Oncology for Children and Youth specializes in the comprehensive treatment of children and adolescents, with a particular focus on primary tumors of the musculoskeletal system, including solid tumors, soft tissue sarcomas, malignant bone sarcomas, and histiocytosis. It is a reference center for the treatment of primary malignant bone tumors in children. The department offers a wide range of services, from diagnosis and oncological surgery to modern chemotherapy and radiotherapy treatments. In addition to standard treatments, we also offer immunotherapy and targeted therapies within the framework of clinical trials, as well as individualized programs based on molecular testing results.

Main Research Activities

The activities of IMC include scientific research aimed at improving treatment outcomes and the quality of life for our patients, medical services and treatment (closely integrated with research), educational activities (post-graduate training for medical personnel and public health education), and publishing. IMC has been involved in implementing scientific projects funded through various domestic and international funding streams for many years. The Oncological clinic, with many years of experience, is actively involved in scientific research projects and clinical trials, as well as in the development of modern oncological therapies to improve patient care. It also engages in joint scientific and therapeutic collaborations with both national and international scientific societies.

Core Facilities

IMC comprises specialized clinics, research departments, and outpatient specialist centers, all working together to provide comprehensive medical, diagnostic, and therapeutic care. The Institute treats both common childhood conditions and complex cases such as pediatric cancers, congenital malformations, metabolic disorders, prematurity, rare diseases, and severe perinatal infections. The Oncological clinic has a multidisciplinary team providing comprehensive care for cancer patients (surgery, radiotherapy, systemic treatment, psychotherapy and physiotherapy). The team includes clinical and surgical oncologists, radiation therapists, nurses, rehabilitation specialists, radiologists, biologists, and pathomorphology specialists. For years, a model of coordinated specialized care has been implemented at the Clinic.

Presentation of the Institute

Established in 1988 and transformed into a Research Institute by the Ministry of Health in 1997, the Polish Mother's Memorial Hospital - Research Institute (PMMH-RI) in Lódz is one of the largest highly specialised medical centres in Poland, serving as a tertiary referral centre. PMMH employs highly qualified specialists with strong professional and scientific credentials, including national consultants in various fields of medicine.

Comprehensive care for mother and child from the first days of pregnancy, through the neonatal period, childhood and into adulthood. We treat gynaecological, endocrine and oncological conditions. We were the birthplace of neonatal cardiac surgery in Poland.

As a leading referral centre in perinatology, gynaecology, paediatrics and oncology, PMMH-RI delivers highly specialised care for patients with the most complex medical conditions.

As a unique research and clinical institution, PMMH-RI continues to advance personalised medicine, innovative diagnostics and evidence-based treatment, contributing to improved outcomes for patients in Poland and across Europe.

Main Research Activities

The Institute is recognised for its multidisciplinary approach, providing advanced treatment for breast, gynaecological and other solid tumours while ensuring continuity of care from diagnosis through treatment and follow-up.

PMMH-RI was the first centre in Poland to introduce an interdisciplinary oncology programme for pregnant women, establishing a pioneering model of care for patients requiring cancer treatment during pregnancy.

PMMH-RI offers multidisciplinary oncological care through five dedicated oncology units:

• Department of Oncology
• Department of Surgical Oncology and Breast Diseases
• Department of Operative Gynaecology and Gynaecologic Oncology
• Department of Operative Gynaecology, Endoscopy and Gynaecologic Oncology
• Department of Gynaecology, Gynaecological Oncology and Endometriosis Treatment

In April 2022, the Oncology Clinical Research Support Centre (CWBK) was established with support from the Medical Research Agency (ABM) to facilitate both commercial and non-commercial clinical trials.

The Institute has extensive experience in international multicentre clinical research and currently conducts more than 130 clinical trials, including approximately 45 active oncology clinical trials. (date from 2025)

Research areas include:

• Breast cancer
• Endometrial cancer
• Ovarian and fallopian tube cancers
• Lung cancer
• Peritoneal malignancies
• Solid tumours and thoracic cancers

PMMH-RI combines excellence in patient care with scientific innovation and international collaboration.

We are member of ERKNet (European Reference Network for Rare Kidney Diseases) since January 2022.

We are active participation in international research networks and collaborative projects.

Core Facilities

The Institute operates 30 specialist departments and clinics, supported by a comprehensive outpatient care network, providing advanced medical services, research and education. It provides professional healthcare in 2 hospital complexes:

obstetric-gynaecological and paediatrics, offering a wide range of diagnostic services.

The oncology pathway is supported by specialised diagnostic services, including the Department of Pathomorphology, the Department of Genetics, the Department of Diagnostic Imaging and the Department of Laboratory Diagnostics, ensuring comprehensive and personalised cancer care.

Our Institute undertakes both scientific, research and development activities and wide and dynamic as well as didactic and training activity.

Presentation of the Centre

The Greater Poland Cancer Centre (GPCC) is one of the largest comprehensive cancer centres in Poland and Europe. Supervised by the Greater Poland Voivodeship authorities, it provides advanced oncological care, hospitalising over 33,300 patients annually. Each year, the Centre performs approximately 7,000 surgical procedures, 7,000 radiotherapy treatments, and handles nearly 168,000 outpatient visits (as of 2024). GPCC operates across three locations: its main site in Poznań and branches in Kalisz and Piła. These modern facilities offer a full spectrum of radiation oncology services, including diagnostics, treatment, and research.

Staff

At GPCC, we prioritise professional excellence. Most wards and departments are led by university professors, while many of our physicians hold doctoral degrees and multiple specialisations. Half of our nursing staff have university degrees, with many holding specialist licences. Our diagnostic and therapeutic teams also include psychologists, medical physicists, physiotherapists, biologists, and laboratory diagnosticians.

Science at GPCC

GPCC is accredited for residency programmes in multiple oncological and surgical fields. It hosts four university departments: Biotechnology (Prof. A. Mackiewicz), Cancer Pathology and Prophylactics (Prof. A. Marszałek), Head and Neck Surgery (Prof. W. Golusiński), and Electroradiology (Prof. J. Malicki). The Centre is also home to the editorial offices of four international scientific journals: Reports of Practical Oncology and Radiotherapy, Letters in Oncology Science, Contemporary Oncology, and Journal of Contemporary Brachytherapy.

Centre Overview

AidPort – Clinical Trials Hospital, located in Skórzewo near Poznan, is a modern medical centre specialising in the conduct of clinical trials and providing patients with access to innovative therapies. The facility was purpose-built to support clinical research in accordance with the highest international quality and safety standards (ICH-GCP). It combines the expertise of experienced physicians, clinical research coordinators and nursing staff with state-of-the-art infrastructure, enabling the efficient delivery of clinical studies in collaboration with pharmaceutical sponsors, contract research organisations (CROs) and academic institutions. AidPort’s mission is to advance evidence-based medicine and improve patient access to innovative treatment options through high-quality clinical research.

Main Research Areas

AidPort conducts clinical trials across multiple therapeutic areas, with particular expertise in haematology, oncology, neurology, cardiology, gynaecology and osteoporosis. The centre also participates in studies involving vaccines and infectious diseases. A strong emphasis is placed on clinical research that provides patients with access to innovative therapies for cancer, haematological disorders and chronic diseases where standard treatment options may be limited. Through close collaboration with national and international sponsors, AidPort contributes to the development of novel medicinal products and advanced therapeutic strategies, supporting scientific progress and improving the quality of patient care.

Key Infrastructure

The hospital offers comprehensive infrastructure specifically designed for clinical research. Its facilities include an infusion therapy unit, consultation and procedure rooms, a biopsy suite, a bone densitometry laboratory, and a hospital pharmacy with a cytotoxic drug preparation unit. The centre also provides dedicated workspaces for clinical research monitors, continuous environmental monitoring systems for investigational medicinal products, backup power supply and quality systems ensuring full compliance with applicable regulatory and Good Clinical Practice (GCP) requirements. This advanced infrastructure enables the efficient and reliable conduct of clinical trials to the highest operational and quality standards.

Educational Activities

AidPort actively supports the professional development of healthcare professionals and promotes awareness of clinical research among patients and the wider medical community. The centre provides internal training programmes for research teams, collaborates with experts across a broad range of medical specialties and participates in initiatives aimed at increasing understanding of innovative therapies and the role of clinical trials in advancing healthcare. Education is an integral part of AidPort’s mission, contributing to the continuous improvement of healthcare quality and the development of medical innovation.